e-Profile Login and ID Quick Search
Illegal Importation - Federal and State Enforcement of Reimportation Laws (Resolution No. 100-1-04)
Resolution No. 100-1-04
Title: Illegal Importation – Federal and State Enforcement of Reimportation Laws
Action: PASSED
Whereas, the importation of prescription medications from Canada and other foreign sources is illegal and an imminent danger to the public health and safety that poses a serious risk to patients; and
Whereas, the illegal importation of prescription medications is different from the legal process of reimportation which allows for the importation of Food and Drug Administration (FDA) approved prescription medications from FDA registered facilities employing Good Manufacturing Practices (GMP’s); and
Whereas, NABP continues to oppose illegal importation because of its threat to the patient health and safety; and
Whereas, various state and local governments have endorsed and are seeking to direct patients enrolled in prescription medication programs funded by state and local governments to obtain prescription medications from Canada and other foreign sources; and
Whereas, FDA has been unable to engage in legal action that stops states and local governments from endorsing, promoting, and engaging in the illegal importation of prescription medications;
THEREFORE BE IT RESOLVED that NABP continue to oppose the illegal importation of medications; and
THEREFORE BE IT FURTHER RESOLVED that NABP express to FDA the concerns of its member boards and strongly urge the FDA or appropriate legal authority to pursue actions against state and local governments for endorsing, promoting, or engaging in the illegal importation of medications.
(Resolution passed at NABP’s 100th Annual Meeting, Chicago, IL)
